These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8445421)

  • 1. Ifosfamide and mitoxantrone as first-line chemotherapy for metastatic breast cancer.
    Perez JE; Machiavelli M; Leone BA; Romero A; Rabinovich MG; Vallejo CT; Bianco A; Lacava JA; Rodriguez R; Cuevas MA
    J Clin Oncol; 1993 Mar; 11(3):461-6. PubMed ID: 8445421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ifosfamide and vinorelbine as first-line chemotherapy for metastatic breast cancer.
    Leone BA; Vallejo CT; Romero AO; Perez JE; Cuevas MA; Lacava JA; Sabatini CL; Dominguez ME; Rodriguez R; Barbieri MR; Ortiz EH; Salvadori MA; Acuña LA; Acuña JM; Langhi MJ; Amato S; Machiavelli MR
    J Clin Oncol; 1996 Nov; 14(11):2993-9. PubMed ID: 8918497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ifosfamide given by continuous-intravenous infusion in association with vinorelbine in patients with anthracycline-resistant metastatic breast cancer: a phase I-II clinical trial.
    Campisi C; Fabi A; Papaldo P; Tomao S; Massidda B; Zappala A; Ionta MT; Cognetti F
    Ann Oncol; 1998 May; 9(5):565-7. PubMed ID: 9653499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ifosfamide given by continuous-intravenous infusion in association with vinorelbine in patients with anthracycline-resistant metastatic breast cancer: A phase I-II clinical trial.
    Campisi C; Fabi A; Papaldo P; Tomao S; Massidda B; Zappala A; Ionta MT; Cognetti F
    Cancer Chemother Pharmacol; 1999; 44 Suppl():S1-4. PubMed ID: 10602901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination of mitoxantrone-vinorelbine as first-line chemotherapy for metastatic breast carcinoma].
    Ferrero JM; Pivot X; Namer M; Wendling JL; Frenay M; François E; Hoch M; Teissier E
    Bull Cancer; 1995 Mar; 82(3):202-7. PubMed ID: 7655148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
    Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
    Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vinorelbine as first-line chemotherapy for metastatic breast carcinoma.
    Romero A; Rabinovich MG; Vallejo CT; Perez JE; Rodriguez R; Cuevas MA; Machiavelli M; Lacava JA; Langhi M; Romero Acuña L
    J Clin Oncol; 1994 Feb; 12(2):336-41. PubMed ID: 8113840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combination of ifosfamide and mitoxantrone as salvage therapy in patients with advanced ovarian cancer.
    Nardi M; Della Giulia M; Pollera CF; Marolla P; Ruggeri EM; Iacovelli A; Atlante G; Calabresi F
    Cancer Chemother Pharmacol; 1996; 38(3):298-301. PubMed ID: 8646807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of paclitaxel and ifosfamide as a salvage treatment in metastatic breast cancer.
    Murad AM; Guimaraes RC; Amorim WC; Morici AC; Ferreira-Filho AF; Schwartsmann G
    Breast Cancer Res Treat; 1997 Aug; 45(1):47-53. PubMed ID: 9285116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy with ifosfamide, cisplatin, and vinorelbine in advanced squamous cell carcinoma of the cervix.
    Vallejo CT; Pérez JE; Domínguez ME; Leone BA; Machiavelli MR; Lacava JA; Romero AO; Ortiz EH; Grasso S; Amato S; Rodríguez R; Barbieri M; Romero Acuña J; Focaccia G; Suttora G; Scenna M; Boughen JM; Romero Acuña LA; Langhi MJ
    Am J Clin Oncol; 2000 Oct; 23(5):481-6. PubMed ID: 11039508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
    Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY
    Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two novel high-dose treatment regimens for metastatic breast cancer--ifosfamide, carboplatin, plus etoposide and mitoxantrone plus thiotepa: outcomes and toxicities.
    Fields KK; Elfenbein GJ; Perkins JB; Hiemenz JW; Janssen WE; Zorsky PE; Ballester OF; Kronish LE; Foody MC
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):59-66. PubMed ID: 8211217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel with mitoxantrone, fluorouracil, and high-dose leucovorin in the treatment of metastatic breast cancer: a phase II trial.
    Hainsworth JD; Jones SE; Mennel RG; Blum JL; Greco FA
    J Clin Oncol; 1996 May; 14(5):1611-6. PubMed ID: 8622079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel with mitoxantrone with or without 5-fluorouracil and high-dose leucovorin in the treatment of metastatic breast cancer.
    Greco FA; Hainsworth JD
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-61-S17-64. PubMed ID: 9374096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vinorelbine and paclitaxel as first-line chemotherapy in metastatic breast cancer.
    Romero Acuña L; Langhi M; Pérez J; Romero Acuña J; Machiavelli M; Lacava J; Vallejo C; Romero A; Fasce H; Ortiz E; Grasso S; Amato S; Rodríguez R; Barbieri M; Leone B
    J Clin Oncol; 1999 Jan; 17(1):74-81. PubMed ID: 10458220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of vinblastine, ifosfamide, and gallium combination chemotherapy in metastatic urothelial carcinoma.
    Einhorn LH; Roth BJ; Ansari R; Dreicer R; Gonin R; Loehrer PJ
    J Clin Oncol; 1994 Nov; 12(11):2271-6. PubMed ID: 7525884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma.
    Bennett JM; Muss HB; Doroshow JH; Wolff S; Krementz ET; Cartwright K; Dukart G; Reisman A; Schoch I
    J Clin Oncol; 1988 Oct; 6(10):1611-20. PubMed ID: 3049953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ifosfamide + mitoxantrone in advanced breast cancer previously treated with anthracyclines.
    Bellmunt J; Morales S; Navarro M; Solé LA
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S81-4. PubMed ID: 2347056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ifosfamide and cisplatin as neoadjuvant chemotherapy for advanced cervical carcinoma.
    Leone B; Vallejo C; Perez J; Cuevas MA; Machiavelli M; Lacava J; Focaccia G; Ferreyra R; Suttora G; Romero A; Castaldi J; Arroyo A; Rabinovich M
    Am J Clin Oncol; 1996 Apr; 19(2):132-5. PubMed ID: 8610635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.
    Gasparini G; Caffo O; Barni S; Frontini L; Testolin A; Guglielmi RB; Ambrosini G
    J Clin Oncol; 1994 Oct; 12(10):2094-101. PubMed ID: 7931479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.